Please login to the form below

Not currently logged in
Email:
Password:

Martin Brass

This page shows the latest Martin Brass news and features for those working in and with pharma, biotech and healthcare.

Fishawack acquires Blue Latitude Health

Fishawack acquires Blue Latitude Health

Front row L-R: Martin Brass, Gail Flockhart . The Fishawack Group has added another string to its bow, acquiring creative consultancy Blue Latitude Health.

Latest news

  • Blue Latitude Health expands into the US Blue Latitude Health expands into the US

    Co-founder and managing director at Blue Latitude Health Martin Brass said: “We are very excited to be expanding and opening an office in New York City, where we will be

  • Blue Latitude retains Janssen contract Blue Latitude retains Janssen contract

    Martin Brass (pictured), Blue Latitude co-founder and managing director, added: “We are absolutely thrilled to extend our partnership with Janssen to include their brand teams in the EMEA region and

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics